Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Weight Gain D015430 101 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Brain Ischemia D002545 89 associated lipids
Seizures D012640 87 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Arteriosclerosis D001161 86 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Alzheimer Disease D000544 76 associated lipids
Stomach Ulcer D013276 75 associated lipids
Leukemia D007938 74 associated lipids
Coronary Disease D003327 70 associated lipids
Colitis D003092 69 associated lipids
Melanoma D008545 69 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Neuroblastoma D009447 66 associated lipids
Reperfusion Injury D015427 65 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Pain D010146 64 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Weight Loss D015431 56 associated lipids
Nerve Degeneration D009410 53 associated lipids
Parkinson Disease D010300 53 associated lipids
Asthma D001249 52 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Osteosarcoma D012516 50 associated lipids
Thrombosis D013927 49 associated lipids
Psoriasis D011565 47 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Hypotension D007022 41 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Arthritis D001168 41 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Peritonitis D010538 38 associated lipids
Nervous System Diseases D009422 37 associated lipids
Lung Diseases D008171 37 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Glomerulonephritis D005921 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Epilepsy D004827 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Fever D005334 35 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Burns D002056 34 associated lipids
Memory Disorders D008569 33 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Acute Lung Injury D055371 33 associated lipids
Uremia D014511 33 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Stroke D020521 32 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Cardiomegaly D006332 31 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Proteinuria D011507 30 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neuralgia D009437 28 associated lipids
Endotoxemia D019446 27 associated lipids
Angina Pectoris D000787 27 associated lipids
Hyperinsulinism D006946 27 associated lipids
Brain Diseases D001927 27 associated lipids
Gastritis D005756 27 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Nasal Polyps D009298 26 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Ascites D001201 25 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Ulrich CD Lexipafant in severe acute pancreatitis: the final word? 2001 Curr Gastroenterol Rep pmid:11276374
Ishizuka S et al. Acid exposure stimulates the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells: effects on platelet-activating factor receptor expression. 2001 Am. J. Respir. Cell Mol. Biol. pmid:11306440
Lukashova V et al. G-protein-independent activation of Tyk2 by the platelet-activating factor receptor. 2001 J. Biol. Chem. pmid:11309383
Grassi S and Pettorossi VE Synaptic plasticity in the medial vestibular nuclei: role of glutamate receptors and retrograde messengers in rat brainstem slices. 2001 Prog. Neurobiol. pmid:11311461
Marcano H et al. Effect of dopamine on platelet activating factor induced-pulmonary edema in isolated and perfused rabbit lungs. 2001 Respir Physiol pmid:11348642
Wild MD and Roudebush WE Platelet-activating factor improves intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11349157
Wu C et al. Evidence for the autocrine induction of capacitation of mammalian spermatozoa. 2001 J. Biol. Chem. pmid:11350972
Lee T et al. Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase. 2001 Arch. Biochem. Biophys. pmid:11368182
Iwase M et al. Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. 2001 Crit. Care Med. pmid:11373429
Jehle R et al. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. 2001 Biochim. Biophys. Acta pmid:11420174
Kulikov VI and Muzya GI Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs. 2001 Biochemistry Mosc. pmid:11421815
Virchow JC et al. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. 2001 Clin. Exp. Allergy pmid:11422147
Wang H et al. Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine. 2001 Br. J. Pharmacol. pmid:11429396
Miguel BG et al. Increase of phosphoinositide hydrolysis and diacylglycerol production by PAF in isolated rat liver nuclei. 2001 Prostaglandins Other Lipid Mediat. pmid:11444588
Hirashima Y et al. Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage--open clinical trial to investigate efficacy and safety. 2001 Neurol. Med. Chir. (Tokyo) pmid:11381675
Liu XH et al. Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. 2001 Pediatr. Res. pmid:11385142
Mi B and Maleczka RE A Nozaki-Hiyama-Kishi Ni(II)/Cr(II) coupling approach to the phomactins. 2001 Org. Lett. pmid:11388849
Elzi DJ et al. Ionomycin causes activation of p38 and p42/44 mitogen-activated protein kinases in human neutrophils. 2001 Am. J. Physiol., Cell Physiol. pmid:11401859
Tiemann U et al. Platelet-activating factor (PAF)-like activity, localization of PAF receptor (PAF-R) and PAF-acetylhydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy. 2001 Prostaglandins Other Lipid Mediat. pmid:11403499
Tong N et al. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. 2001 Eur. J. Neurosci. pmid:11403684
Roudebush WE Role of platelet-activating factor in reproduction: sperm function. 2001 Asian J. Androl. pmid:11404790
Briton-Jones C et al. The effects of follicular fluid and platelet-activating factor on motion characteristics of poor-quality cryopreserved human sperm. 2001 J. Assist. Reprod. Genet. pmid:11411433
Mizuno S et al. Role of PAF in acute liver injury after extended hepatectomy: overexpression of PAF receptor mRNA in Kupffer cells. 2001 Dig. Dis. Sci. pmid:11414308
Tsoukatos DC et al. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. 2001 Biochem. J. pmid:11439095
Roudebush WE and Diehl JR Platelet-activating factor content in boar spermatozoa correlates with fertility. 2001 Theriogenology pmid:11396471
de Meis L Role of the sarcoplasmic reticulum Ca2+-ATPase on heat production and thermogenesis. 2001 Biosci. Rep. pmid:11725862
Rodrigo L et al. Hydrolysis of platelet-activating factor by human serum paraoxonase. 2001 Biochem. J. pmid:11171072
Del Sorbo L et al. Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. 2001 Eur. J. Immunol. pmid:11180101
Karasawa K [Physiological role of novel metabolic pathway of platelet-activating factor(PAF): PAF-dependent transacetylation]. 2001 Tanpakushitsu Kakusan Koso pmid:11193332
Urasaki T et al. Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway. 2001 J. Leukoc. Biol. pmid:11200053
Hauser CJ et al. PAF-mediated Ca2+ influx in human neutrophils occurs via store-operated mechanisms. 2001 J. Leukoc. Biol. pmid:11200069
Jeon SY et al. Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways. 2001 Ann. Otol. Rhinol. Laryngol. pmid:11201815
Wittwer T et al. Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation. 2001 J. Heart Lung Transplant. pmid:11257563
Zhang J et al. Effect of buyang huanwu decoction on platelet activating factor content in arterial blood pre- and post-arterial thrombosis in rats. 2001 J Tradit Chin Med pmid:12014136
Qian C et al. Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor. 2001 Pharmacol. Res. pmid:11529688
Persidsky Y et al. Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. 2001 J. Neuroimmunol. pmid:11240016
Bachert C Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. 2001 Allergy pmid:11243500
Roudebush WE et al. Impact of blood serum insulin-like growth factor I on platelet-activating factor in bull spermatozoa. 2001 Domest. Anim. Endocrinol. pmid:11164329
Giménez R and Aguilar J Cytidine (5') diphosphocholine-induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats. 2001 Neurosci. Lett. pmid:11165772
Goudevenos J et al. Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty. 2001 Eur. J. Clin. Invest. pmid:11168434
Galimi F et al. Hepatocyte growth factor is a regulator of monocyte-macrophage function. 2001 J. Immunol. pmid:11145707
Arese M et al. HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment. 2001 J. Immunol. pmid:11145723
Rabinowitz SS et al. Platelet-activating factor in infants at risk for necrotizing enterocolitis. 2001 J. Pediatr. pmid:11148517
Gandhi CR et al. A23187 causes release of inositol phosphates from cultured rat Kupffer cells. 2001 Eur. J. Pharmacol. pmid:11245846
Denis MA et al. Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease. 2001 Scand. J. Gastroenterol. pmid:11252412
Storey RF et al. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood. 2001 Platelets pmid:11674863
Camici M and Sagripanti A Plasma platelet activating factor in nephrotic syndrome. 2001 Minerva Med. pmid:11675576
Kohno S and Nabe T [Inflammatory mediators (leukotrienes, thromboxane A2, tachykinins and others)]. 2001 Nippon Rinsho pmid:11676130
Pettorossi VE and Grassi S Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. 2001 Acta Otolaryngol Suppl pmid:11677732
Wielockx B et al. Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor. 2001 J. Hepatol. pmid:11682033
Dutra PM et al. Platelet-activating factor modulates a secreted phosphatase activity of the trypanosomatid parasite Herpetomonas muscarum muscarum. 2001 Curr. Microbiol. pmid:11683365
Mathison R et al. Regulation of leukocyte adhesion to heart by the tripeptides feG and feG(NH2). 2001 Can. J. Physiol. Pharmacol. pmid:11599779
Havt A et al. The renal effects of Bothrops jararacussu venom and the role of PLA(2) and PAF blockers. 2001 Toxicon pmid:11600146
Claman P Platelet activating factor does not improve intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11717679
Caplan MS and Jilling T The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis. 2001 Lipids pmid:11724457
Rosa MS et al. Platelet-activating factor (PAF) modulates peritoneal mouse macrophage infection by Leishmania amazonensis. 2001 Curr. Microbiol. pmid:11375661
Beales IL Effect of platelet-activating factor on gastrin release from cultured rabbit G-cells. 2001 Dig. Dis. Sci. pmid:11284466
McHowat J et al. Endothelial cell PAF synthesis following thrombin stimulation utilizes Ca(2+)-independent phospholipase A(2). 2001 Biochemistry pmid:11732912
Sirolli V et al. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. 2001 Thromb. Haemost. pmid:11583316
Fukunaga K et al. Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. 2001 J. Biol. Chem. pmid:11560941
Zhao L et al. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. 2001 Br. J. Pharmacol. pmid:11564653
Bhatia M et al. Inflammatory mediators as therapeutic targets in acute pancreatitis. 2001 Curr Opin Investig Drugs pmid:11566005
Emingil G et al. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. 2001 J. Periodontol. pmid:11525434
Thomet OA et al. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils. 2001 Clin. Exp. Allergy pmid:11529903
Watanabe S et al. Suppression of platelet-activating factor generation and modulation of arachidonate metabolism by dietary enrichment with (n-9) eicosatrienoic acid or docosahexaenoic acid in mouse peritoneal cells. 2001 Prostaglandins Other Lipid Mediat. pmid:11534547
Stafforini DM PAF acetylhydrolase gene polymorphisms and asthma severity. 2001 Pharmacogenomics pmid:11535107
Steer ML Relationship between pancreatitis and lung diseases. 2001 Respir Physiol pmid:11535257
Tokutomi T et al. Production of platelet-activating factor by neuronal cells in the rat brain with cold injury. 2001 Neurol. Res. pmid:11547929
Chemler SR et al. Enantioselective synthesis of the oxadecalin core of phomactin A via a highly stereoselective Diels-Alder reaction. 2001 Org. Lett. pmid:11554815
Johnson CD et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. 2001 Gut pmid:11115824
Kavakli K et al. Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease. 2001 Haemophilia pmid:11554936
Rozenfeld RA et al. Role of gut flora on intestinal group II phospholipase A2 activity and intestinal injury in shock. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11557516
Thom SR et al. Roles for platelet-activating factor and *NO-derived oxidants causing neutrophil adherence after CO poisoning. 2001 Am. J. Physiol. Heart Circ. Physiol. pmid:11454599
Grosman N Similar effects of ether phospholipids, PAF and lyso-PAF on the Ca(2+)-ATPase activity of rat brain synaptosomes and leukocyte membranes. 2001 Int. Immunopharmacol. pmid:11460312
Marathe GK et al. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. 2001 J. Lipid Res. pmid:11518762
Smith DG et al. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. 2001 J. Neurovirol. pmid:11519483
Hoenstein R et al. Interleukin-2 activates human peripheral blood eosinophils. 2001 Cell. Immunol. pmid:11520078
Carceller E et al. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. 2001 J. Med. Chem. pmid:11520209
Bernatchez PN et al. VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2. 2001 Br. J. Pharmacol. pmid:11522612
Hourton D et al. Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity. 2001 Eur. J. Biochem. pmid:11502209
Velasquez LA et al. PAF receptor and PAF acetylhydrolase expression in the endosalpinx of the human Fallopian tube: possible role of embryo-derived PAF in the control of embryo transport to the uterus. 2001 Hum. Reprod. pmid:11473946
Akisu M et al. The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis. 2001 Eur J Pediatr Surg pmid:11475112
Chang PY et al. Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids. 2001 Circulation pmid:11479258
Küçükhüseyin C et al. Renovascular actions of adenosine in the isolated perfused rat kidney: possible underlying mechanisms. 2001 J Basic Clin Physiol Pharmacol pmid:11868905
Tibiriçá E Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants. 2001 Cardiovasc Drug Rev pmid:11830750
Uhlmann D et al. Importance of microcirculatory disturbances in the pathogenesis of pancreatitis. 2001 Zentralbl Chir pmid:11753796
Closa D et al. Absorption and effects of 3-(N-phenylamino)-1,2-propanediol esters in relation to toxic oil syndrome. 2001 Lipids pmid:11768157
Hiran T et al. Evidence for the involvement of the NADPH oxidase enzyme complex in the optimal accumulation of Platelet-activating factor in the human cell line PLB-985. 2001 Prostaglandins Other Lipid Mediat. pmid:11785782
Binisti C et al. Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A(2) inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazines. 2001 Eur J Med Chem pmid:11738488
Ribeiro JM and Francischetti IM Platelet-activating-factor-hydrolyzing phospholipase C in the salivary glands and saliva of the mosquito Culex quinquefasciatus. 2001 J. Exp. Biol. pmid:11807106
Biffl WL et al. Neutrophil apoptosis is delayed by trauma patients' plasma via a mechanism involving proinflammatory phospholipids and protein kinase C. 2001 Surg Infect (Larchmt) pmid:12593704
Jin Y et al. [The effect of autocrine factors on development of early embryos of mouse]. 2001 Shi Yan Sheng Wu Xue Bao pmid:12549014
Kuijpers TW et al. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. 2001 Clin. Exp. Immunol. pmid:11298128
Teeling JL et al. Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages--studies in a rat model. 2001 Br. J. Haematol. pmid:11298603
Teather LA et al. Differential interaction of platelet-activating factor and NMDA receptor function in hippocampal and dorsal striatal memory processes. 2001 Neurobiol Learn Mem pmid:11300737
Aiboshi J et al. Blood transfusion and the two-insult model of post-injury multiple organ failure. 2001 Shock pmid:11303730
Ilveskero S et al. Procoagulant activity on platelets adhered to collagen or plasma clot. 2001 Arterioscler. Thromb. Vasc. Biol. pmid:11304482
Hattar K et al. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors. 2001 J. Immunol. pmid:11342652
Berdyshev EV et al. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. 2001 FASEB J. pmid:11641243
Alam N et al. Additional bioactive Lyso-PAF congeners from the sponge Spirastrella abata. 2001 J. Nat. Prod. pmid:11325244